<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0185-3325</journal-id>
<journal-title><![CDATA[Salud mental]]></journal-title>
<abbrev-journal-title><![CDATA[Salud Ment]]></abbrev-journal-title>
<issn>0185-3325</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0185-33252017000600265</article-id>
<article-id pub-id-type="doi">10.17711/sm.0185-3325.2017.034</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Misuse of pharmaceuticals by regular psychostimulant users is linked to mental health problems]]></article-title>
<article-title xml:lang="es"><![CDATA[El uso indebido de psicofármacos entre los usuarios regulares de psicoestimulantes está relacionado con problemas de salud mental]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Salom]]></surname>
<given-names><![CDATA[Caroline L.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Burns]]></surname>
<given-names><![CDATA[Lucinda A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alati]]></surname>
<given-names><![CDATA[Rosa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,The University of Queensland Institute for Social Sciences Research ]]></institution>
<addr-line><![CDATA[Brisbane ]]></addr-line>
<country>Australia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,The University of New South Wales National Drug and Alcohol Research Centre ]]></institution>
<addr-line><![CDATA[Sydney ]]></addr-line>
<country>Australia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2017</year>
</pub-date>
<volume>40</volume>
<numero>6</numero>
<fpage>265</fpage>
<lpage>270</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0185-33252017000600265&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0185-33252017000600265&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0185-33252017000600265&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction: Misuse of pharmaceutical drugs, particularly by young people, is an issue of rising concern. Poly-substance use is common among regular psychostimulant users (RPU), and mental health problems are associated with pharmaceutical misuse, but RPU do not generally acknowledge their use as problematic.  Objective: To examine links between mental health and misuse of non-prescription pharmaceuticals in a group of regular users of illicit psychostimulants.  Method: Face to face structured interviews were conducted in April 2015 with 763 regular users of illicit psychostimulants as part of the Annual Ecstasy and Related Drugs Reporting System study in Australia.  Results: At least half of the RPU in this study reported extra-medical or misuse of pharmaceuticals in the last six months in addition to regular use of illicit psychostimulants. Higher levels of psychological distress were recorded for RPU who also reported recent illicit use of opioids, antidepressants, benzodiazepines, or over-the-counter (OTC) codeine. Recent misuse of benzodiazepines or OTC codeine was associated with self-reported mental health problems and having attended a mental health professional. Those reporting recent misuse of opioids were at increased risk of mental health problems and more likely to record high levels of psychological distress, but less likely to have received prescription medications for their mental health problem.  Discussion and conclusion: Regular users of illicit psychostimulants who also misuse pharmaceuticals are at increased risk of mental health problems, even after accounting for their use of illicit psychostimulants. Screening of this group for mental health problems is recommended.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción: El uso indebido de psicofármacos, particularmente entre los jóvenes, es un tema de creciente preocupación. El policonsumo de sustancias es común entre los usuarios regulares de psicoestimulantes (URP), y, pese a que hay problemas de salud mental asociados con el uso indebido de medicamentos, los URP generalmente no reconocen su consumo como problemático.  Objetivo: Examinar las relaciones entre la salud mental y el uso indebido de psicofármacos no prescritos en un grupo de URP.  Método: Se realizaron entrevistas cara a cara con 763 URP como parte del Estudio Anual del Sistema de Reporte de Éxtasis y Drogas Relacionadas en Australia.  Resultados: Al menos la mitad de los URP en este estudio informaron el uso extramédico o indebido de psicofármacos en los últimos seis meses, además del uso regular de psicoestimulantes ilícitos. Se hallaron niveles más altos de distrés psicológico para los URP, quienes también informaron de un uso ilícito reciente de codeína, opiáceos, antidepresivos o benzodiazepinas sin prescripción médica. El uso indebido reciente de codeína o benzodiazepinas sin prescripción se asoció a problemas autorreportados de salud mental y a asistencia a consulta con un profesional de salud mental. Aquellos que informaron el uso indebido reciente de opioides mostraron mayor riesgo de problemas de salud mental y mayor probabilidad de registrar altos niveles de distrés psicológico, pero menor probabilidad de haber recibido psicofármacos prescritos para su problema de salud mental.  Discusión y conclusión: Los URP que también consumen indebidamente psicofármacos están en mayor riesgo de presentar problemas de salud mental, incluso después de considerar su consumo de psicoestimulantes ilícitos. Se recomienda una evaluación por tamizaje para problemas de salud mental en este grupo.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Non-prescription drugs]]></kwd>
<kwd lng="en"><![CDATA[substance abuse]]></kwd>
<kwd lng="en"><![CDATA[mental disorders]]></kwd>
<kwd lng="en"><![CDATA[substance-related disorders]]></kwd>
<kwd lng="en"><![CDATA[recreational drugs]]></kwd>
<kwd lng="es"><![CDATA[Medicamentos sin receta]]></kwd>
<kwd lng="es"><![CDATA[abuso de sustancias]]></kwd>
<kwd lng="es"><![CDATA[trastornos relacionados con sustancias]]></kwd>
<kwd lng="es"><![CDATA[uso indebido]]></kwd>
<kwd lng="es"><![CDATA[drogas recreativas]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andrews]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Slade]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interpreting scores on the Kessler Psychological Distress Scale (K10).]]></article-title>
<source><![CDATA[Australian and New Zealand Journal of Public Health]]></source>
<year>2001</year>
<volume>25</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>494-7</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="book">
<collab>Australian Government</collab>
<source><![CDATA[National Pharmaceutical Drug Misuse Framework for Action (2012-2015)]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Canberra ]]></publisher-loc>
<publisher-name><![CDATA[Australian Government]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<collab>Australian Institute of Health and Welfare</collab>
<source><![CDATA[National Drug Strategy Household Survey 2016: Detailed Findings Drug Statistics]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Canberra ]]></publisher-loc>
<publisher-name><![CDATA[Australian Institute of Health and Welfare]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bachhuber]]></surname>
<given-names><![CDATA[M. A.]]></given-names>
</name>
<name>
<surname><![CDATA[Maughan]]></surname>
<given-names><![CDATA[B. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Mitra]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Feingold]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Starrels]]></surname>
<given-names><![CDATA[J. L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prescription monitoring programs and emergency department visits involving benzodiazepine misuse: Early evidence from 11 United States metropolitan areas]]></article-title>
<source><![CDATA[International Journal of Drug Policy]]></source>
<year>2016</year>
<numero>28</numero>
<issue>28</issue>
<page-range>120-3</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Connor]]></surname>
<given-names><![CDATA[J. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Gullo]]></surname>
<given-names><![CDATA[M. J.]]></given-names>
</name>
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[A. B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polysubstance use: diagnostic challenges, patterns of use and health]]></article-title>
<source><![CDATA[Current Opinion in Psychiatry]]></source>
<year>2014</year>
<volume>27</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>269-75</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dunlop]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Harms: How much, how many, how often?]]></article-title>
<source><![CDATA[Drug and Alcohol Review]]></source>
<year>2011</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>332-3</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hides]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Lubman]]></surname>
<given-names><![CDATA[D. I.]]></given-names>
</name>
<name>
<surname><![CDATA[Devlin]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Cotton]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Aitken]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Gibbie]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Hellard]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reliability and Validity of the Kessler 10 and Patient Health Questionnaire among Injecting Drug Users]]></article-title>
<source><![CDATA[Australian &amp; New Zealand Journal of Psychiatry]]></source>
<year>2007</year>
<volume>41</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>166-8</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="book">
<collab>International Narcotics Control Board</collab>
<source><![CDATA[Availability of Internationally Controlled Drugs: Ensuring adequate access for medical and scientific purposes]]></source>
<year>2016</year>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[United Nations]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaye]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Darke]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?]]></article-title>
<source><![CDATA[Addiction]]></source>
<year>2012</year>
<volume>107</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>467-77</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaye]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Darke]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Torok]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diversion and misuse of pharmaceutical stimulants among illicit drug users]]></article-title>
<source><![CDATA[Addiction Research &amp; Theory]]></source>
<year>2014</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>109-16</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[B. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Wells]]></surname>
<given-names><![CDATA[B. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Pawson]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[LeClair]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Parsons]]></surname>
<given-names><![CDATA[J. T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Combinations of prescription drug misuse and illicit drugs among young adults]]></article-title>
<source><![CDATA[Addictive Behaviors]]></source>
<year>2014</year>
<volume>39</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>941-4</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kessler]]></surname>
<given-names><![CDATA[R. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Andrews]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Colpe]]></surname>
<given-names><![CDATA[L. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Hiripi]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Mroczek]]></surname>
<given-names><![CDATA[D. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Normand]]></surname>
<given-names><![CDATA[S.-L. T.]]></given-names>
</name>
<name>
<surname><![CDATA[Zaslavsky]]></surname>
<given-names><![CDATA[A. M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Short screening scales to monitor population prevalences and trends in non-specific psychological distress]]></article-title>
<source><![CDATA[Psychological Medicine]]></source>
<year>2002</year>
<volume>32</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>959-76</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kessler]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Mroczek]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Final version of our Non-specific Psychological Distress Scale]]></source>
<year>1994</year>
<publisher-loc><![CDATA[Ann Arbor ]]></publisher-loc>
<publisher-name><![CDATA[Survey Research Centre of Institute for Social Research, University of Michigan]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lasopa]]></surname>
<given-names><![CDATA[S. O.]]></given-names>
</name>
<name>
<surname><![CDATA[Striley]]></surname>
<given-names><![CDATA[C. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Cottler]]></surname>
<given-names><![CDATA[L. B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diversion of prescription stimulant drugs among 10-18-year-olds]]></article-title>
<source><![CDATA[Current Opinion in Psychiatry]]></source>
<year>2015</year>
<volume>28</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>292</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lloyd]]></surname>
<given-names><![CDATA[B. K.]]></given-names>
</name>
<name>
<surname><![CDATA[McElwee]]></surname>
<given-names><![CDATA[P. R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends over time in characteristics of pharmaceutical drug-related ambulance attendances in Melbourne]]></article-title>
<source><![CDATA[Drug and Alcohol Review]]></source>
<year>2011</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>271-80</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lubman]]></surname>
<given-names><![CDATA[D. I.]]></given-names>
</name>
<name>
<surname><![CDATA[Allen]]></surname>
<given-names><![CDATA[N. B.]]></given-names>
</name>
<name>
<surname><![CDATA[Rogers]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Cementon]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Bonomo]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The impact of co-occurring mood and anxiety disorders among substance-abusing youth]]></article-title>
<source><![CDATA[Journal of Affective Disorders]]></source>
<year>2007</year>
<volume>103</volume>
<numero>1-3</numero>
<issue>1-3</issue>
<page-range>105-12</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maxwell]]></surname>
<given-names><![CDATA[J. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The prescription drug epidemic in the United States: A perfect storm]]></article-title>
<source><![CDATA[Drug and Alcohol Review]]></source>
<year>2011</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>264-70</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[K. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Shear]]></surname>
<given-names><![CDATA[P. K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: Contributions of polydrug use]]></article-title>
<source><![CDATA[Drug and Alcohol Dependence]]></source>
<year>2007</year>
<volume>87</volume>
<numero>2-3</numero>
<issue>2-3</issue>
<page-range>303-11</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nicholas]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Roche]]></surname>
<given-names><![CDATA[A. M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pharmaceutical Drug Misuse in Australia: Complex Problems, Balanced Responses]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Adelaide ]]></publisher-loc>
<publisher-name><![CDATA[National Centre for Education and Training on Addiction]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Bruno]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmaceutical drugs: The delicate balance between reducing pain and reducing harm]]></article-title>
<source><![CDATA[Drug and Alcohol Review]]></source>
<year>2011</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>233-5</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Bruno]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Implementing real-time prescription drug monitoring: Are we ready?]]></article-title>
<source><![CDATA[Drug and Alcohol Review]]></source>
<year>2014</year>
<volume>33</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>463-5</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="book">
<collab>NSW Government</collab>
<source><![CDATA[Strengthening mental health care in NSW]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Sydney ]]></publisher-loc>
<publisher-name><![CDATA[NSW Health]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="book">
<collab>Queensland Government</collab>
<source><![CDATA[Chief Psychiatrist Policy: The treatment and care of patients]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Brisbane ]]></publisher-loc>
<publisher-name><![CDATA[Queensland Health]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Salom]]></surname>
<given-names><![CDATA[C. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Betts]]></surname>
<given-names><![CDATA[K. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[G. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Najman]]></surname>
<given-names><![CDATA[J. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Alati]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictors of comorbid polysubstance use and mental health disorders in young adults-a latent class analysis]]></article-title>
<source><![CDATA[Addiction]]></source>
<year>2016</year>
<volume>111</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>156-64</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sindicich]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Burns]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Australian trends in ecstasy and related drug markets 2014: Findings from the Ecstasy and Related Drugs Reporting System (EDRS)]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Sydney ]]></publisher-loc>
<publisher-name><![CDATA[National Drug and Alcohol Research Centre]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sindicich]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Stafford]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Breen]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Australian Trends in Ecstasy and related Drug Markets 2015. Findings from the Ecstasy and Related Drugs Reporting System (EDRS)]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Sydney ]]></publisher-loc>
<publisher-name><![CDATA[National Drug and Alcohol Research Centre]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[G. W.]]></given-names>
</name>
<name>
<surname><![CDATA[Farrell]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Bunting]]></surname>
<given-names><![CDATA[B. P.]]></given-names>
</name>
<name>
<surname><![CDATA[Houston]]></surname>
<given-names><![CDATA[J. E.]]></given-names>
</name>
<name>
<surname><![CDATA[Shevlin]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patterns of polydrug use in Great Britain: Findings from a national household population survey]]></article-title>
<source><![CDATA[Drug and Alcohol Dependence]]></source>
<year>2011</year>
<volume>113</volume>
<numero>2-3</numero>
<issue>2-3</issue>
<page-range>222-8</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilkins]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Sweetsur]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Griffiths]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recent trends in pharmaceutical drug use among frequent injecting drug users, frequent methamphetamine users and frequent ecstasy users in New Zealand, 2006-2009]]></article-title>
<source><![CDATA[Drug and Alcohol Review]]></source>
<year>2011</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>255-63</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Worley]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prescription drug monitoring programs, a response to doctor shopping: Purpose, effectiveness, and directions for future research]]></article-title>
<source><![CDATA[Issues in Mental Health Nursing]]></source>
<year>2012</year>
<volume>33</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>319-28</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
